手持反射式共聚焦显微镜作为黑素瘤原位癌手术管理标准护理的成功实施
该研究纳入117例慢加急性肝衰竭/慢加急性肝衰竭合并黑素瘤(LM/LMM)连续病例(2015-2023),评估手持反射式共聚焦显微镜(HH-RCM)术前标测对手术切缘、管理决策及随访结局的影响,并与历史队列(n=94,2003-2014)比较。结果显示HH-RCM标测使27%病例管理改变,组织学切缘清除率96.5%显著高于历史队列81%(p=0.001),局部复发率1.6%低于历史队列25%。
要点
- HH-RCM术前标测可检测60%病例的亚临床LM,中位标测时间14分钟。
- HH-RCM标测使27%病例管理改变,多为局限手术联合咪喹莫特或咪喹莫特单药。
- HH-RCM辅助手术后组织学切缘清除率96.5%,显著高于历史队列81%。
核心结论
- 将HH-RCM整合为标准护理可为LM/LMM提供更个性化治疗策略,并筛选适合非手术治疗的患者。
研究设计与样本
- 纳入117例连续LM/LMM病例(2015-2023),评估HH-RCM检测亚临床LM及浸润成分的诊断准确性。
- 主要终点为组织学切缘状态及基于HH-RCM标测结果的管理改变。
- 切缘与随访结局与HH-RCM引入前历史队列(n=94,2003-2014)比较。
主要发现
- HH-RCM在60%(n=60)病例中检测到亚临床LM,中位标测时间14分钟(范围4-50)。
- 27%(n=33)病例因标测改变管理,其中局限手术联合咪喹莫特15例,咪喹莫特单药14例。
- 96.5%患者组织学切缘清除,中位组织学切缘3.0 mm,显著高于历史队列81%(中位2.0 mm)(p=0.001)。
- 检测亚临床LM范围的敏感度94%(95%CI 80.4-99.3),特异度84%(95%CI 70.3-92.7)。
- 检测LMM的阴性预测值94%(95%CI 84.4-97.7),75% initially missed LMM(n=12)在HH-RCM标测中被识别。
关键数值与推荐
- HH-RCM检测亚临床LM范围敏感度94%(95%CI 80.4-99.3),特异度84%(95%CI 70.3-92.7)。
- HH-RCM检测LMM阴性预测值94%(95%CI 84.4-97.7)。
- 组织学切缘清除率96.5%,中位切缘3.0 mm,历史队列81%(中位2.0 mm)(p=0.001)。
临床怎么用
- HH-RCM可作为LM/LMM术前标测工具,辅助确定手术切缘并指导管理决策。
- HH-RCM标测可识别适合非手术治疗(如咪喹莫特)的患者。
局限性
- 与历史队列比较可能存在时间偏倚。
- 样本来自单中心,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reflectance confocal microscopy (RCM) has shown promise in predicting surgical outcomes by non-invasively detecting subclinical lentigo maligna (melanoma) (LM/LMM). OBJECTIVES: To assess the effects of presurgical mapping using handheld RCM (HH-RCM) on surgical treatment, follow-up outcomes and management decisions. METHODS: A total of 117 consecutive LM/LMM cases (2015-2023) were included. The diagnostic accuracy of HH-RCM in detecting subclinical LM and invasive components was evaluated. The primary endpoints included histological margin status and changes in management based on the outcomes of the HH-RCM mapping procedure. Margin and follow-up outcomes were compared to a historical cohort before HH-RCM was introduced in our center (n = 94) (2003-2014). RESULTS: HH-RCM detected subclinical LM in 60% (n = 60) of cases. The median mapping duration was 14 min (range 4-50). In 27% (n = 33), the mapping procedure resulted in modified management, the majority consisting of limited surgery with adjuvant imiquimod (n = 15) or imiquimod monotherapy (n = 14). The remaining cases (n = 84) underwent HH-RCM-assisted surgery. Histological margins were cleared in 96.5% of the patients with a median histological margin of 3.0 mm, significantly higher than 81% in the historical cohort (median 2.0 mm) (p = 0.001). The sensitivity and specificity for detecting the extent of subclinical LM were 94% (95% CI 80.4-99.3) and 84% (95% CI 70.3-92.7), respectively. The negative predictive value for the detection of LMM was 94% (95% CI 84.4-97.7), and 75% of the initially missed LMM (n = 12) were identified during the HH-RCM mapping procedure. The study cohort had a 1.6% local recurrence rate compared with 25% in the historical cohort. CONCLUSIONS: Integrating HH-RCM as the standard of care could lead to more personalized treatment strategies for LM/LMM and allows for the selection of patients suitable for nonsurgical treatment.
引用
- Elshot YS, Lasso Peña DJP, Zupan-Kajcovski B, et al. Successful implementation of handheld reflectance confocal microscopy as the standard of care in the (surgical) management of lentigo maligna (melanoma). J Eur Acad Dermatol Venereol. 2024. PMID: 38923079. doi:10.1111/jdv.20210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。